Psomagen KRX:950200KOSDAQ
소마젠 · Korean news coverage and regulatory filings, organized.
Articles, 24h0
Articles, 7 days0
DART filings, 7 days0
Articles tracked0since Sep 11
In Q2 2026, Psomagen reported revenue of ₩8m, down 27.3% year on year, and operating profit of ₩0m. Psomagen (소마젠) appeared in 0 Korean news articles and 0 DART filings over the past seven days.
Filing signals Turnaround Screener
Psomagen quarterly results separate, KRW
| Quarter | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| Q2 2026 | ₩8m | -27.3% | ₩0m margin 1.5% | ₩2m |
| Q1 2026 | ₩9m | +12.4% | −₩0m margin −5.6% | −₩0m |
| Q4 2025 derived | ₩12m | +18.3% | −₩0m margin −0.7% | −₩0m |
| Q3 2025 | ₩11m | +25.6% | −₩0m margin −1.0% | −₩0m |
| Q2 2025 | ₩11m | +76.1% | −₩0m margin −1.2% | −₩1m |
| Q1 2025 | ₩8m | +10.6% | −₩1m margin −16.2% | −₩1m |
| Q4 2024 derived | ₩10m | +58.2% | −₩0m margin −3.6% | −₩1m |
| Q3 2024 | ₩9m | +47.7% | −₩1m margin −11.7% | −₩1m |
Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.
Psomagen top stories 2 weeks, by number of outlets
No story covered by multiple outlets in the past two weeks.
Latest Psomagen news Korean headlines
No articles yet.